Zdrowie i gospodarka · 26/09/2011

FDA Reorganizes CDER into Two Offices Under Office of Medical Policy

The FDA has reorganized the Center for Drug Evaluation and Research (CDER) by establishing two offices, Office of Prescription Drug Promotion (OPDP) and Office of Medical Policy Initiatives (OMPI), under the Office of Medical Policy, to improve its functions and delegations of authority.